Boston Scientific sales hit $1.89B in Q3 & more – 4 GI company key notes

Here are four recent news updates on key gastroenterology and endoscopy companies.

Boston Scientific generated approximately $1.89 billion in sales for the third quarter of 2015, a 9 percent growth in operational revenue growth.

Shares of EndoChoice hit a 52-week low of $9.71 this week, according to a District of Columbia Progressive report. The company's stock has a 50-day moving average of $12.78 and a 200-day moving average of $15.02.

Shares of Exact Sciences dropped 58.1 percent during the past four weeks, according to Insider Trading Report. The company's shares have a one-year high of $32.85 and a one-year low of $6.79.

The endoscopy division of FUJIFILM Medical Systems will feature its ultrasound processor Sonart and EB-530US ultrasound bronchoscope at the annual meeting of the American College of Chest Physicians Oct. 24 to Oct. 28 in Montreal, Canada.

If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast